1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Poultry Vaccines Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Poultry Vaccines Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Prevalence of Poultry Diseases
5.2 Market Opportunities
- 5.2.1 Government Support for Mass Vaccination Drives and Innovative Schemes
5.3 Future Trends
- 5.3.1 Advancements in vectored and combination vaccines
5.4 Impact of Drivers and Restraints
6. Europe Poultry Vaccines Market Regional Analysis
6.1 Europe Poultry Vaccines Market Overview
6.2 Europe Poultry Vaccines Market Revenue 2021-2031 (US$ Million)
6.3 Europe Poultry Vaccines Market Forecast Analysis
7. Europe Poultry Vaccines Market Analysis – by Type
7.1 Broiler
- 7.1.1 Overview
- 7.1.2 Broiler: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Layer
- 7.2.1 Overview
- 7.2.2 Layer: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Poultry Vaccines Market Analysis – by Technology
8.1 Live Attenuated Vaccines
- 8.1.1 Overview
- 8.1.2 Live Attenuated Vaccines: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Inactivated Vaccines
- 8.2.1 Overview
- 8.2.2 Inactivated Vaccines: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Recombinant Vaccines?Dosage Form
- 8.3.1 Overview
- 8.3.2 Recombinant Vaccines?Dosage Form : Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. Europe Poultry Vaccines Market Analysis – by Route Of Administration
9.1 Drinking water
- 9.1.1 Overview
- 9.1.2 Recombinant Vaccines?Dosage Form : Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Intramuscular
- 9.2.1 Overview
- 9.2.2 Recombinant Vaccines?Dosage Form : Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Subcutaneous
- 9.3.1 Overview
- 9.3.2 Recombinant Vaccines?Dosage Form : Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. Europe Poultry Vaccines Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Poultry Vaccines Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.1.1.1 Europe Poultry Vaccines Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.1.1 UK: Europe Poultry Vaccines Market Breakdown, by Type
- 10.1.1.1.2 UK: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.1.3 UK: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.1.1.2 Germany:
Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.2.1 Germany: Europe Poultry Vaccines Market Breakdown, by Type
- 10.1.1.2.2 Germany: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.2.3 Germany: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.1.1.3 France:
Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.3.1 France: Europe Poultry Vaccines Market Breakdown, by Type
- 10.1.1.3.2 France: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.3.3 France: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.1.1.4 Russia:
Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.4.1 Russia: Europe Poultry Vaccines Market Breakdown, by Type
- 10.1.1.4.2 Russia: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.4.3 Russia: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.1.1.5 Italy:
Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.5.1 Italy: Europe Poultry Vaccines Market Breakdown, by Type
- 10.1.1.5.2 Italy: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.5.3 Italy: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.1.1.6 Rest of Europe:
Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Poultry Vaccines Market Breakdown, by Type
- 10.1.1.6.2 Rest of Europe: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.1.1.6.3 Rest of Europe: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Poultry Vaccines Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Boehringer Ingelheim International GmbH.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Zoetis Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Phibro Animal Health Corp.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Dechra Pharmaceuticals PLC.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Elanco Animal Health Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Ceva.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Vaccinova AB.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights